BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35805156)

  • 1. Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.
    Perbellini O; Cavallini C; Chignola R; Galasso M; Scupoli MT
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot.
    Haas A; Weckbecker G; Welzenbach K
    Cytometry A; 2008 Sep; 73(9):799-807. PubMed ID: 18548611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
    Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
    BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T; Yao S; Zhang X; Guo Y
    Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synergistic cytotoxic effects of rapamycin and idarubicin on human acute T-cell lymphoblastic leukemia Jurkat cells].
    Zhao YM; Wu KN; Wang YJ; Wu GQ; Cao WJ; Yu XH; Huang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 40(5):482-8. PubMed ID: 21984149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
    Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
    BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H
    Soto-Mercado V; Mendivil-Perez M; Jimenez-Del-Rio M; Fox JE; Velez-Pardo C
    Leuk Res; 2020 Aug; 95():106389. PubMed ID: 32540572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.
    Liou JT; Lin CS; Liao YC; Ho LJ; Yang SP; Lai JH
    Acta Pharmacol Sin; 2017 Aug; 38(8):1171-1183. PubMed ID: 28603286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
    Siqueira RP; Caetano MMM; de Souza LÂ; Dos Passos PMS; Simaroli NB; Barros MVA; de Souza APM; de Oliveira LL; Silva-Júnior A; Fietto JLR; Teixeira RR; Teixeira FR; Bressan GC
    Toxicol In Vitro; 2020 Jun; 65():104777. PubMed ID: 31962201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PI-3-K and AKT Amplifies Kv1.3 Inhibitor-Induced Death of Human T Leukemia Cells.
    Bergermann T; Born L; Ferguson F; Latkovic P; Scheul A; Sonnenschein N; Leanza L; Keitsch S; Sehl C; Wilker B; Edwards MJ; Zoratti M; Paradisi C; Kohnen M; Szabo I; Becker KA; Carpinteiro A
    Cell Physiol Biochem; 2019; 53(S1):1-10. PubMed ID: 31804046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis.
    Størvold GL; Landskron J; Strozynski M; Arntzen MØ; Koehler CJ; Kalland ME; Taskén K; Thiede B
    J Proteomics; 2013 Oct; 91():344-57. PubMed ID: 23933134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck.
    Maulon L; Guérin S; Ricci JE; Breittmayer DF; Auberger P
    Blood; 1998 Jun; 91(11):4232-41. PubMed ID: 9596671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
    Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
    J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation.
    Kwon J; Devadas S; Williams MS
    Free Radic Biol Med; 2003 Aug; 35(4):406-17. PubMed ID: 12899942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.
    Ma W; Liu Y; Lei P; Zhu M; Pan X
    Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detecting phospho-signaling protein of bone marrow leukemia cells by phospho-signaling flow cytometry].
    Li HM; Zeng YR; Chen FX; Wu LP; Wei FG; Tao J; Lu HM; Wu ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1176-9. PubMed ID: 22040966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.